Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 4/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.34 |
| ▸ | AGTR1 | P30556 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14593296 | 0.86 | LMNA (0.38) | LMNAGAA | |
| SCHEMBL13558751 | 0.79 | PRKCA (0.36) | LMNAALDH1A1 | |
| SCHEMBL22179402 | 0.79 | CNR2 (0.32) | — | |
| SCHEMBL14626978 | 0.78 | LMNA (0.33) | LMNA | |
| SCHEMBL15159899 | 0.76 | LMNA (0.31) | LMNAALDH1A1 | |
| SCHEMBL12066831 | 0.76 | LMNA (0.46) | LMNAGAAALOX12AGTR1CYP1A2 | |
| SCHEMBL594114 | 0.76 | — | — | |
| SCHEMBL5035786 | 0.73 | LMNA (0.35) | LMNAGAA | |
| SCHEMBL9575036 | 0.72 | — | — | |
| SCHEMBL14680853 | 0.71 | PRKCA (0.35) | LMNACYP3A4CYP2C9CYP2C19ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3778612-B1 | PHOSPHATE DERIVATIVES AND USE THEREOF | SHANGHAI SHENGYUE PHARMACEUTICAL TECH CO LTD (CN) | 2025-02-12 | — | — | EP | disclosed |
| CN-110317230-B | Phosphate derivatives and use thereof | 上海昇悦医药科技有限公司 | 2023-11-07 | — | — | CN | disclosed |
| EP-3778612-A1 | PHOSPHATE DERIVATIVES AND USE THEREOF | Zhu, Qing (CN) | 2021-02-17 | — | — | EP | disclosed |
| EP-3778612-A1 | PHOSPHATE DERIVATIVES AND USE THEREOF | Zhu, Qing (CN) | 2021-02-17 | — | — | EP | disclosed |
| US-20210030773-A1 | PHOSPHATE DERIVATIVES AND USE THEREOF | Shanghai Shengyue Pharmaceutical Technology Co., Ltd. (CN) | 2021-02-04 | — | — | US | disclosed |
| CN-110317230-A | Phosphoric acid salt derivative and application thereof | 朱青 | 2019-10-11 | — | — | CN | disclosed |
| WO-2019184866-A1 | PHOSPHATE DERIVATIVES AND USE THEREOF | 朱青 | 2019-10-03 | — | — | WO | disclosed |
| EP-2746370-B1 | Engine oil | AFTON CHEMICAL CORP (US) | 2018-02-14 | — | — | EP | disclosed |
| CN-104844486-A | Amino propanediol derivatives, preparation method, drug compositions and uses thereof | INST MATERIA MEDICA CAMS | 2015-08-19 | — | — | CN | disclosed |
| US-8888907-B2 | Solid phase change ink compositions comprising oxazolines | XEROX CORPORATION (US) | 2014-11-18 | — | — | US | disclosed |
| EP-2502619-A2 | Systems and methods for delivery of materials | Landec Corporation (US) | 2012-09-26 | — | — | EP | disclosed |
| US-20110009571-A1 | SYSTEMS AND METHODS FOR DELIVERY OF MATERIALS | ALCON RESEARCH, LLC | 2011-01-13 | — | — | US | disclosed |
| US-20100004124-A1 | Systems and methods for delivery of materials for agriculture and aquaculture | LANDEC CORPORATION | 2010-01-07 | — | — | US | disclosed |
| US-20090263346-A1 | Systems and methods for delivery of drugs | LANDEC CORPORATION | 2009-10-22 | — | — | US | disclosed |
| US-20090246155-A1 | Compositions and methods for personal care | LANDEC CORPORATION | 2009-10-01 | — | — | US | disclosed |
| WO-2009073192-A2 | SYSTEMS AND METHODS FOR DELIVERY OF MATERIALS | LANDEC CORPORATION (US) | 2009-06-11 | — | — | WO | disclosed |
| US-7169817-B2 | Bis-aromatic alkanols | IRM LLC (BM) | 2007-01-30 | — | — | US | disclosed |
| EP-0008507-B1 | DERIVATIVES OF 2-OXAZOLINES AS ANTIOXIDANTS AND COMPOSITIONS THEREOF | UNIROYAL, INC. (US) | 1985-02-13 | — | — | EP | disclosed |
| EP-0008507-A1 | Derivatives of 2-oxazolines as antioxidants and compositions thereof | UNIROYAL, INC. (US) | 1980-03-05 | — | — | EP | disclosed |
| US-4055592-A | ATHEROSCLEROSIS | MERCK & CO., INC. (US) | 1977-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090263346-A1 | Systems and methods for delivery of drugs | CYCS, CTRC, PPIC | LMNA 1770/4885GAA 535/4885ALOX12 1921/4885 |
| US-20090246155-A1 | Compositions and methods for personal care | PPIC, CYCS, CTRC | LMNA 1158/4885GAA 717/4885ALOX12 1778/4885 |
| US-20100004124-A1 | Systems and methods for delivery of materials for agriculture and aquaculture | CYCS, PCCA, CRYAA | LMNA 2119/4885GAA 597/4885ALOX12 1985/4885 |
| US-20210030773-A1 | PHOSPHATE DERIVATIVES AND USE THEREOF | CXCL12, MIF, FGF23 | LMNA 4000/4885GAA 2390/4885ALOX12 1504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.